You can find the annual or quarterly income statement of Eloxx Pharmaceuticals Ord Shs here for insights into the performance and operational efficiency of Eloxx Pharmaceuticals Ord Shs.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
Operating expenses
--3.79M
R&D expenses
--1.66M
Operating profit
---3.79M
Net non-operating interest income (expenses)
Non-operating interest income
--23.00K
Non-operating interest expense
--29.00K
Special income (expenses)
--56.00K
Other non-operating income (expenses)
---9.00K
Income before tax
---3.75M
Income after tax
---3.75M
Net income from continuous operations
---3.75M
Net income attributable to controlling interests
---3.75M
Net income attributable to common shareholders
---3.75M
Basic earnings per share
---0.86
Diluted earnings per share
---0.86
Dividend per share
--0.00
Currency unit
USD
Audit opinions
--
FAQs
What is the income statement?
The income statement, also known as the profit and loss statement, shows the revenues, expenses, profits, and losses of the company over a specific accounting period.